ArticlePloS one2012

A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease.

Peter A Sloane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.